GLP-1 Side Effects A-Z: The Complete Reference Guide
Every known side effect of semaglutide, tirzepatide, and retatrutide organized alphabetically with frequency data, severity ratings, management strategies, and guidance on when to contact your provider.
Medical Disclaimer: This guide is for informational purposes only. Side effect experiences vary by individual. Always report concerning symptoms to your healthcare provider. Do not adjust or stop medication without medical guidance.
Understanding potential side effects is essential for anyone starting or considering semaglutide, tirzepatide, or retatrutide. This comprehensive A-Z reference covers every documented side effect with practical, actionable information.
How to Use This Guide
Each side effect entry includes:
- Frequency: How common it is (Very Common: 10%+, Common: 1-10%, Uncommon: 0.1-1%, Rare: less than 0.1%)
- Medications affected: Which GLP-1s are associated with this side effect
- Typical timing: When it usually appears and resolves
- Management: What you can do about it
- When to call your provider: Warning signs that need attention
A-C
Abdominal Pain
Frequency: Very Common (5-20%) | All GLP-1 medications
Usually mild cramping or discomfort in the upper abdomen, most common during dose titration. Eating smaller meals and avoiding high-fat foods helps significantly. If pain is severe, persistent, or radiates to the back, contact your provider immediately as this could indicate pancreatitis.
Acid Reflux (GERD)
Frequency: Common (3-8%) | All GLP-1 medications
Slowed gastric emptying can worsen acid reflux in some patients. Eat smaller meals, avoid eating within 3 hours of bedtime, and elevate the head of your bed. OTC antacids or prescription PPIs may help. Typically improves as the body adjusts.
Appetite Loss (Severe)
Frequency: Common (varies) | All GLP-1 medications
Reduced appetite is the intended therapeutic effect, but some patients experience near-complete appetite loss that makes eating feel impossible. If you are eating less than 800 calories daily or losing weight too rapidly (more than 4 lbs per week), contact your provider about dose reduction.
Belching
Frequency: Common (3-7%) | All GLP-1 medications
Excessive belching or burping relates to slowed gastric emptying. Eat slowly, avoid carbonated beverages, and do not talk while eating. Usually resolves within 4-8 weeks.
Bloating
Frequency: Common (4-10%) | All GLP-1 medications
Abdominal bloating and gas are related to delayed gastric emptying. Smaller, more frequent meals and avoiding gas-producing foods (beans, cruciferous vegetables, carbonated drinks) help. Simethicone (Gas-X) provides relief for many patients.
Constipation
Frequency: Very Common (10-24%) | All GLP-1 medications
One of the most common side effects, caused by slowed GI motility and reduced food/fiber intake. Increase fiber intake, drink more water, and consider a fiber supplement (psyllium husk). Stool softeners (docusate) or osmotic laxatives (MiraLAX) may be needed. Notify your provider if constipation is severe or you go more than 3 days without a bowel movement.
D-F
Diarrhea
Frequency: Very Common (17-30%) | All GLP-1 medications
Often alternates with constipation, especially during titration. Stay hydrated with electrolyte drinks. Avoid high-fat, greasy foods. Usually improves within 4-8 weeks. Persistent diarrhea (more than 2 weeks) warrants provider consultation.
Dizziness
Frequency: Common (2-7%) | All GLP-1 medications
May indicate dehydration or low blood sugar (especially in diabetic patients on other glucose-lowering medications). Ensure adequate hydration and regular meals. Stand up slowly from sitting or lying positions.
Dyspepsia (Indigestion)
Frequency: Common (3-9%) | All GLP-1 medications
Upper abdominal discomfort, burning, or fullness after eating. Smaller meals, avoiding spicy foods, and eating slowly help. Antacids provide short-term relief.
Fatigue
Frequency: Common (3-11%) | All GLP-1 medications
Can result from reduced caloric intake, dehydration, or the body's adjustment to the medication. Ensure adequate protein and calorie intake (do not drop below 1,200 calories daily), stay hydrated, and maintain regular sleep. Fatigue that persists beyond 8 weeks should be evaluated.
Flatulence
Frequency: Common (4-8%) | All GLP-1 medications
Increased gas production from altered digestion. Avoid gas-producing foods during titration. Typically resolves as the body adjusts.
G-J
Gallbladder Problems
Frequency: Uncommon (0.5-2%) | All GLP-1 medications
Rapid weight loss from any cause increases gallstone risk. Symptoms include right upper abdominal pain, especially after fatty meals. Maintaining some dietary fat intake (not going completely fat-free) may reduce risk. Report sudden, severe right-sided abdominal pain to your provider.
Gastroesophageal Reflux
See Acid Reflux above.
Hair Loss (Thinning)
Frequency: Common (3-6%) | All GLP-1 medications
Related to rapid weight loss and caloric deficit rather than direct medication effect (telogen effluvium). Usually begins 2-4 months after significant weight loss and resolves within 6-12 months. Adequate protein (80-100g daily), biotin, and iron can help minimize shedding.
Headache
Frequency: Common (4-14%) | All GLP-1 medications
Most common during the first 2-4 weeks. Often related to dehydration or reduced caffeine intake (from drinking less coffee). Stay hydrated, manage caffeine reduction gradually, and use OTC pain relievers as needed.
Hypoglycemia (Low Blood Sugar)
Frequency: Common in diabetics on other glucose-lowering drugs (3-10%) | Uncommon in non-diabetics | All GLP-1 medications
Risk is highest when combined with insulin or sulfonylureas. Symptoms include shakiness, sweating, confusion, and rapid heartbeat. Keep glucose tablets or juice available. Your provider may need to adjust other diabetes medications when starting a GLP-1.
Injection Site Reactions
Frequency: Common (2-8%) | All injectable GLP-1 medications
Redness, itching, swelling, or mild pain at the injection site. Rotate injection sites (abdomen, thigh, upper arm). Allow medication to reach room temperature before injecting. If reactions are severe or spreading, contact your provider.
K-N
Kidney Function Changes
Frequency: Rare (less than 1%) | All GLP-1 medications
Severe GI side effects (vomiting, diarrhea) can cause dehydration that impacts kidney function. This is typically reversible with adequate hydration. Patients with pre-existing kidney disease should be monitored more closely. Report inability to keep fluids down for more than 24 hours.
Muscle Cramps
Frequency: Common (2-5%) | All GLP-1 medications
May relate to dehydration, electrolyte imbalances, or reduced nutrient intake. Stay hydrated, ensure adequate magnesium, potassium, and calcium intake, and stretch regularly.
Nausea
Frequency: Very Common (20-44%) | All GLP-1 medications
The most common GLP-1 side effect. Peaks during the first 4-8 weeks and during dose increases. Eat small, frequent meals. Avoid fatty, greasy, or spicy foods. Ginger tea, ginger chews, and peppermint can help. Your provider may prescribe ondansetron (Zofran) for severe cases. Slower titration is the most effective prevention strategy.
O-R
Pancreatitis
Frequency: Rare (less than 0.5%) | All GLP-1 medications
A serious but rare side effect. Symptoms include severe, persistent abdominal pain that may radiate to the back, nausea, and vomiting. Stop the medication and seek emergency care if you experience these symptoms. Risk is higher in patients with a history of pancreatitis, gallstones, or heavy alcohol use.
Rapid Heart Rate (Tachycardia)
Frequency: Uncommon (1-3%) | Semaglutide, Tirzepatide
Small increases in resting heart rate (2-4 bpm) have been observed in clinical trials. Usually clinically insignificant. Report sustained resting heart rate above 100 bpm or palpitations to your provider.
S-V
Sulfur Burps
Frequency: Common (5-15%, based on patient reports) | All GLP-1 medications
Egg-smelling burps are frequently reported by GLP-1 users, likely related to slowed digestion and food fermenting in the stomach. Reduce sulfur-rich foods (eggs, broccoli, onions), eat smaller meals, and try peppermint tea. Often improves after the first few weeks.
Taste Changes
Frequency: Common (3-8%, based on patient reports) | All GLP-1 medications
Some patients report food tasting different, particularly sweets tasting overly sweet or meat tasting unpleasant. This may relate to changes in gut-brain signaling. Usually adjusts over time.
Thyroid Concerns
Frequency: Theoretical risk (Rare in humans) | All GLP-1 medications
All GLP-1 medications carry a boxed warning about medullary thyroid carcinoma (MTC) based on rodent studies. While this risk has not been confirmed in humans, GLP-1s are contraindicated in patients with personal or family history of MTC or MEN2. Report any neck lump, hoarseness, or difficulty swallowing.
Vomiting
Frequency: Very Common (9-24%) | All GLP-1 medications
Often accompanies nausea, particularly during titration. Same management strategies as nausea. If you cannot keep food or fluids down for more than 24 hours, contact your provider or go to urgent care for IV hydration.
When to Seek Immediate Medical Attention
- Severe abdominal pain that does not resolve with rest and dietary changes
- Signs of allergic reaction: facial swelling, difficulty breathing, severe rash
- Inability to keep fluids down for more than 24 hours
- Signs of severe dehydration: dark urine, dizziness, rapid heartbeat, confusion
- Sudden vision changes
- Neck lump or persistent hoarseness
- Severe hypoglycemia that does not respond to glucose
How to Minimize Side Effects
Universal Side Effect Reduction Strategies
- Slow titration: The single most effective strategy. Longer time at each dose reduces GI side effects by 40-60%
- Small, frequent meals: 5-6 small meals instead of 2-3 large ones
- Adequate hydration: 64+ ounces of water daily, more if experiencing diarrhea or vomiting
- Avoid trigger foods: Greasy, fried, spicy, and very sweet foods during titration
- Eat slowly: 20-30 minutes per meal minimum
- Protein priority: Protein-rich foods are generally better tolerated and prevent muscle loss
- Time your injection: Many patients find injecting before bed reduces awareness of initial side effects
Frequently Asked Questions
What are the most common GLP-1 side effects?
Nausea (20-44%), diarrhea (17-30%), constipation (10-24%), vomiting (9-24%), and abdominal pain (5-20%) are the most frequently reported side effects across all GLP-1 medications. Most are mild to moderate and improve within the first 8-12 weeks of treatment.
Are GLP-1 side effects permanent?
The vast majority of GLP-1 side effects are temporary and resolve as your body adjusts. Gastrointestinal side effects typically peak during dose titration and diminish at stable doses. Rare serious side effects like pancreatitis require immediate medical attention and discontinuation.
Do semaglutide and tirzepatide have different side effects?
They share most side effects since both activate GLP-1 receptors. However, tirzepatide (a dual GIP/GLP-1 agonist) tends to have slightly lower nausea rates in clinical trials. Side effect profiles also vary by dose — higher doses generally mean more side effects.
When should I go to the ER for GLP-1 side effects?
Seek emergency care for: severe abdominal pain that does not resolve (possible pancreatitis), signs of allergic reaction (swelling, difficulty breathing), severe dehydration (inability to keep fluids down for 24+ hours), or sudden vision changes.
Personalized Side Effect Management with Trimi
Our clinicians guide you through titration with protocols designed to minimize side effects. Compounded semaglutide from $99/mo or tirzepatide from $125/mo.
Get Started TodayMore on Side Effects
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).